Role of Histone Modifications in Acute Kidney Injury Progressing to Chronic Kidney Disease

GUO Shuxian, ZHANG Zeyang, ZHAO Jin, YUAN Jinguo, SUN Shiren

Abstract

 Acute kidney injury (AKI), a clinical syndrome caused by various factors, is characterized by a rapid decline in kidney function in a short period of time. AKI affects the short-term prognosis of patients and may also induce chronic kidney disease (CKD). However, the current treatment options for AKI mainly focus on symptom management. Specific therapeutic measures available for the prevention of transition from AKI to CKD are very limited in number. Histones are basic proteins that intricately bind the DNA in chromosomes. After translation, histones undergo various modifications on their amino-terminal tails, such as methylation, acetylation, phosphorylation, ubiquitination, and lactylation, collectively forming the "histone code", which affects the expression of genes mainly by regulating the elastic structure of chromatin or recruiting specific proteins. Extensive research conducted in recent years on histone post-translational modifications (PTMs) has also sparked continuous interest in their association with the AKI-to-CKD transition. Therefore, this paper highlights the significant role of PTMs in the process of AKI developing and progressing to CKD, with a view to finding new approaches to preventing the progression of AKI to CKD.


Keywords: Histone modification,  Acute kidney injury,  Chronic kidney disease,  Methylation,  Acetylation,  Review

 

Full Text:

PDF


References


RONCO C， BELLOMO R， KELLUM J A. Acute kidney injury. Lancet， 2019，394(10212): 1949–1964. doi: 10.1016/s0140-6736(19)32563-2.

FOREMAN K J， MARQUEZ N， DOLGERT A， et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet，2018，392(10159): 2052–2090. doi: 10.1016/s0140-6736(18)31694-5.

NIE L， LIU Y， ZHANG B， et al. Application of histone deacetylase inhibitors in renal interstitial fibrosis. Kidney Dis (Basel)，2020，6(4): 226–235. doi: 10.1159/000505295.

LI Z， LU S， LI X. The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury. Cell Mol Life Sci，2021，78(15): 5731–5741. doi: 10.1007/s00018-021-03892-w.

GUZZI F， CIRILLO L， ROPERTO R M， et al. Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: an updated view. Int J Mol Sci，2019，20(19): 4941. doi: 10.3390/ijms20194941.

NAAS S， SCHIFFER M， SCHÖDEL J. Hypoxia and renal fibrosis. Am J Physiol Cell Physiol，2023，325(4): C999–C1016. doi: 10.1152/ajpcell. 00201.2023.

GEWIN L， ZENT R， POZZI A. Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int，2017，91(3): 552–560. doi: 10.1016/j.kint.2016.08.025.

HUANG R， FU P， MA L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther，2023，8(1): 129. doi: 10.1038/s41392-023-01379-7.

TORCAL GARCIA G， GRAF T. The transcription factor code: a beacon for histone methyltransferase docking. Trends Cell Biol，2021，31(10): 792–800. doi: 10.1016/j.tcb.2021.04.001.

IRIFUKU T， DOI S， SASAKI K， et al. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression. Kidney Int，2016，89(1): 147–157. doi: 10.1038/ki.2015.291.

ZHOU X， ZANG X， PONNUSAMY M， et al. Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining smad7 and phosphatase and tensin homolog expression. J Am Soc Nephrol，2016， 27(7): 2092–2108. doi: 10.1681/asn.2015040457.

MIMURA I， HIRAKAWA Y， KANKI Y， et al. Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes. Sci Rep，2018，8(1): 3779. doi: 10.1038/s41598-018-22180-5.

YU C， XIONG C， TANG J， et al. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression. Theranostics，2021，11(6): 2706–2721. doi: 10.7150/thno.48679.

ZAGER R A， JOHNSON A C. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol，2009，296(5): F1032–1041. doi: 10.1152/ajprenal.00061.2009.

JOHNSON A C， WARE L B， HIMMELFARB J， et al. HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury. Clin J Am Soc Nephrol，2011，6(9): 2108–2113. doi: 10. 2215/cjn.02440311.

SASAKI K， DOI S， NAKASHIMA A， et al. Inhibition of SET domain-containing lysine methyltransferase 7/9 ameliorates renal fibrosis. J Am Soc Nephrol，2016，27(1): 203–215. doi: 10.1681/asn.2014090850.

SHVEDUNOVA M， AKHTAR A. Modulation of cellular processes by histone and non-histone protein acetylation. Nature reviews. Mol Cell Biol，2022，23(5): 329–349. doi: 10.1038/s41580-021-00441-y.

MARUMO T， HISHIKAWA K， YOSHIKAWA M， et al. Epigenetic regulation of BMP7 in the regenerative response to ischemia. J Am Soc Nephrol，2008，19(7): 1311–1320. doi: 10.1681/asn.2007091040.

TANG J， ZHUANG S. Histone acetylation and DNA methylation in ischemia/reperfusion injury. Clin Sci (Lond)，2019，133(4): 597–609. doi: 10.1042/cs20180465.

CIANCIOLO COSENTINO C， SKRYPNYK N I， BRILLI L L， et al. Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol，2013，24(6): 943–953. doi: 10.1681/asn.2012111055.

BIESTERVELD B E， SIDDIQUI A Z， O'CONNELL R L， et al. Valproic acid protects against acute kidney injury in hemorrhage and trauma. J Surg Res，2021，266: 222–229. doi: 10.1016/j.jss.2021.04.014.

ZHANG W， GUAN Y， BAYLISS G， et al. Class Ⅱa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury. Am J Physiol Renal Physiol，2020，319(6): F1015–F1026. doi: 10.1152/ajprenal. 00405.2020.

CHEN F， GAO Q， WEI A， et al. Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis. Cell Death Differ，2021，28(3): 1001–1012. doi: 10.1038/s41418-020-00631-9.


Refbacks

  • There are currently no refbacks.